Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junna Oba

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Cancer|March 19, 2016
Uveal melanoma: From diagnosis to treatment and the science in betweenChandrani Chattopadhyay, Dae Won Kim, Dan S Gombos, et al.
Investigative Ophthalmology & Visual Science|October 10, 2019
Elevated Endogenous SDHA Drives Pathological Metabolism in Highly Metastatic Uveal MelanomaChandrani Chattopadhyay, Junna Oba, Jason Roszik, et al.
Medical Oncology (Northwood, London, England)|March 12, 2021
Estimating copy number using next-generation sequencing to determine ERBB2 amplification statusKohei Nakamura, Eriko Aimono, Junna Oba, et al.
Cell Reports|July 21, 2021
Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategyChristopher J Terranova, Ming Tang, Mayinuer Maitituoheti, et al.
BMC Medicine|October 26, 2016
Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation setJason Roszik, Lauren E Haydu, Kenneth R Hess, et al.
Nature Communications|July 9, 2022
Multi-modal molecular programs regulate melanoma cell stateMiles C Andrews, Junna Oba, Chang-Jiun Wu, et al.
Cancer Discovery|July 18, 2018
CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 BlockadeLimo Chen, Lixia Diao, Yongbin Yang, et al.
Cancer Cell|August 16, 2017
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal MelanomaA Gordon Robertson, Juliann Shih, Christina Yau, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Cancer|March 19, 2016
Uveal melanoma: From diagnosis to treatment and the science in betweenChandrani Chattopadhyay, Dae Won Kim, Dan S Gombos, et al.
Investigative Ophthalmology & Visual Science|October 10, 2019
Elevated Endogenous SDHA Drives Pathological Metabolism in Highly Metastatic Uveal MelanomaChandrani Chattopadhyay, Junna Oba, Jason Roszik, et al.
Medical Oncology (Northwood, London, England)|March 12, 2021
Estimating copy number using next-generation sequencing to determine ERBB2 amplification statusKohei Nakamura, Eriko Aimono, Junna Oba, et al.
Cell Reports|July 21, 2021
Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategyChristopher J Terranova, Ming Tang, Mayinuer Maitituoheti, et al.
BMC Medicine|October 26, 2016
Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation setJason Roszik, Lauren E Haydu, Kenneth R Hess, et al.
Nature Communications|July 9, 2022
Multi-modal molecular programs regulate melanoma cell stateMiles C Andrews, Junna Oba, Chang-Jiun Wu, et al.
Cancer Discovery|July 18, 2018
CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 BlockadeLimo Chen, Lixia Diao, Yongbin Yang, et al.
Cancer Cell|August 16, 2017
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal MelanomaA Gordon Robertson, Juliann Shih, Christina Yau, et al.
Pageof 3